{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:22:45Z","timestamp":1779099765751,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier","isbn-type":[{"value":"9780443315886","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.pmbts.2024.07.012","type":"book-chapter","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:27:47Z","timestamp":1723922867000},"page":"43-58","source":"Crossref","is-referenced-by-count":3,"title":["CRISPR-Cas based genome editing for eradication of human viruses"],"prefix":"10.1016","author":[{"given":"Dharmisha","family":"Solanki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Murjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijai","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2024.07.012_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00580-17","article-title":"History of CRISPR-Cas from encounter with a mysterious repeated sequence to genome editing technology","volume":"200","author":"Ishino","year":"2018","journal-title":"J Bacteriol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00005-016-0427-5","article-title":"CRISPR\/Cas9 immune system as a tool for genome engineering","volume":"65","author":"Hryhorowicz","year":"2017","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/pathogens12010056","article-title":"A landscape of CRISPR\/Cas technique for emerging viral disease diagnostics and therapeutics: progress and prospects","volume":"12","author":"Tripathi","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.590989","article-title":"The use of CRISPR\/Cas9 as a tool to study human infectious viruses","volume":"11","author":"Lin","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003467","article-title":"Emerging infectious diseases: threats to human health and global stability","volume":"9","author":"Morens","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/MMBR.00004-08","article-title":"Cross-species virus transmission and the emergence of new epidemic diseases","volume":"72","author":"Parrish","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cells12101351","article-title":"HIV\u2013host cell interactions","volume":"12","author":"Masenga","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000445852","article-title":"Human immunodeficiency virus (HIV)","volume":"43","author":"Blood","year":"2016","journal-title":"Transfus Med Hemotherapy"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib9","series-title":"HIV\/AIDS Global Epidemic, Infectious Diseases","first-page":"221","author":"Kanki","year":"2023"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib10","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Rio, Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society\u2013USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"Jama"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/ijms24021563","article-title":"A CRISPR-Cas cure for HIV\/AIDS","volume":"24","author":"Hussein","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.880030","article-title":"Application of CRISPR\/Cas genomic editing tools for HIV therapy: toward precise modifications and multilevel protection","volume":"12","author":"Maslennikova","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib13","unstructured":"Eggleton J.S., Nagalli S. Highly Active Antiretroviral Therapy (HAART). StatPearls. Treasure Island (FL) 2024."},{"key":"10.1016\/bs.pmbts.2024.07.012_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/COH.0b013e328324bbec","article-title":"The biology of CCR5 and CXCR4","volume":"4","author":"Alkhatib","year":"2009","journal-title":"Curr OpHIV AIDS"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.07.012_bib15","doi-asserted-by":"crossref","first-page":"10852","DOI":"10.1038\/s41598-024-61626-x","article-title":"CRISPR\/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1","volume":"14","author":"Khamaikawin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pmbts.2024.07.012_bib16","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1038\/s41598-019-40219-z","article-title":"Isolation of gene-edited cells via knock-in of short glycophosphatidylinositol-anchored epitope tags","volume":"9","author":"Zotova","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03589-21","article-title":"Engineering T-cell resistance to HIV-1 infection via knock-in of peptides from the heptad repeat 2 domain of gp41","volume":"13","author":"Maslennikova","year":"2022","journal-title":"MBio"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib18","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.17601.3","article-title":"Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts","volume":"7","author":"Brown","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02007-17","article-title":"Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles","volume":"92","author":"Tu","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review","volume":"20","author":"Kanda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib21","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112743","article-title":"Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections","volume":"148","author":"Najafi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib24","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib25","doi-asserted-by":"crossref","first-page":"24066","DOI":"10.1021\/acsomega.2c02216","article-title":"HBV cccDNA\u2500 A culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure","volume":"7","author":"Bhat","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.omtn.2023.02.001","article-title":"Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9","volume":"31","author":"Kostyushev","year":"2023","journal-title":"Mol Therapy-Nucleic Acids"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib27","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/vaccines11121862","article-title":"HBV vaccines: advances and development","volume":"11","author":"Mahmood","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.omtm.2020.11.014","article-title":"CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice","volume":"20","author":"Stone","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/v14010004","article-title":"Recent progress and future prospective in HBV cure by CRISPR\/Cas","volume":"14","author":"Yang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib30","doi-asserted-by":"crossref","first-page":"41968","DOI":"10.1038\/srep41968","article-title":"A combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape","volume":"7","author":"Lebbink","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication","volume":"118","author":"Dong","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02888-21","article-title":"CRISPR-Cas9 targeting of hepatitis B virus covalently closed circular DNA generates transcriptionally active episomal variants","volume":"13","author":"Martinez","year":"2022","journal-title":"MBio"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ijms25010334","article-title":"CRISPR\/Cas9 as a new antiviral strategy for treating hepatitis viral infections","volume":"25","author":"Bartosh","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.05.025","article-title":"CRISPR-Cas13b-mediated suppression of hepatitis B virus replication and protein expression","author":"McCoullough","year":"2024","journal-title":"J Hepatol."},{"key":"10.1016\/bs.pmbts.2024.07.012_bib35","unstructured":"Luria L., Cardoza-Favarato G. Human Papillomavirus. StatPearls. Treasure Island (FL) 2024."},{"key":"10.1016\/bs.pmbts.2024.07.012_bib36","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","article-title":"Basic mechanisms of high\u2010risk human papillomavirus\u2010induced carcinogenesis: roles of E6 and E7 proteins","volume":"98","author":"Narisawa\u2010Saito","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib37","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy","volume":"10","author":"Pal","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.omto.2021.12.011","article-title":"Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6\/E7 genes in cervical cancer cells","volume":"24","author":"Tian","year":"2022","journal-title":"Mol Therapy-Oncolytics"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib40","first-page":"3856","article-title":"Reprogrammed CRISPR-Cas13a targeting the HPV16\/18 E6 gene inhibits proliferation and induces apoptosis in E6-transformed keratinocytes","volume":"19","author":"Li","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib41","author":"Cascella","year":"2020","journal-title":"Features, evaluation, Treat coronavirus (COVID-19)"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1071\/MA20013","article-title":"COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don\u2019t","volume":"41","author":"Mackenzie","year":"2020","journal-title":"Microbiol. Aust"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-021-00643-z","article-title":"SARS-CoV-2: from its discovery to genome structure, transcription, and replication","volume":"11","author":"Brant","year":"2021","journal-title":"Cell Biosci"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib44","article-title":"Molecular and serologic diagnostic technologies for SARS-CoV-2","author":"Rando","year":"2022","journal-title":"ArXiv"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","article-title":"CRISPR\u2013Cas12-based detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aar6245","article-title":"CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity","volume":"360","author":"Chen","year":"2018","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib47","first-page":"3","article-title":"CRISPR-Cas system: a promising diagnostic tool for Covid-19","volume":"14","author":"Ebrahimi","year":"2022","journal-title":"Avicenna J Med Biotechnol"},{"key":"10.1016\/bs.pmbts.2024.07.012_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105854","article-title":"A virus-like particle candidate vaccine based on CRISPR\/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2","volume":"225","author":"Wang","year":"2024","journal-title":"Antivir Res"}],"container-title":["Progress in Molecular Biology and Translational Science","CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T15:15:11Z","timestamp":1725981311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117324001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443315886"],"references-count":48,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2024.07.012","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}